HIGHLIGHTS
- who: Toby J. L. Humphrey from the Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK have published the paper: PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V), in the Journal: (JOURNAL) of 31/Oct/2022
- what: The aim of the trial is to determine if preexposure prophylactic treatment reduces the risk of confirmed, symptomatic SARS-CoV-2 infection in vulnerable immunosuppressed patients. The study was initially designed for renal patients, and a key eligibility criterion for the niclosamide and ciclesonide arms are that patients are a member of a renal disease patient . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.